advertiser banner advertiser banner
Digital Issues

Home >  News >  August, 2014

Drug Mix-Up Blinds Patient, Spurs Malpractice Verdict

Cataract patient given methylene blue instead of VisionBlue.

Published: August 22, 2014

A mix-up over sound-alike drugs is at the heart of a $1.5 million jury award earlier this week stemming from a botched cataract procedure that left a patient blind in one eye.

You might say the cataract team at North Carolina Specialty Hospital blue it. Ophthalmologist Timothy Young, MD, PhD, who at the time was practicing with co-defendant North Carolina Eye, Ear, Nose and Throat, in Durham, called for the ophthalmic dye VisionBlue during a cataract removal in 2008, according to news reports. But a nurse instead retrieved methylene blue, a compound sometimes used in endoscopic polypectomies and one that's toxic to eyes.

Both the nurse and a surgical technician testified that they announced what the drug was before it was given to Dr. Young, but he testified that he didn't hear them.

A second procedure to repair the severe damage caused by the mix-up failed, as did a full corneal transplant.

Calls for comment by Outpatient Surgery Magazine to Dr. Young, who now practices in Texas, and to North Carolina Eye, Ear, Nose and Throat, were not returned.

Jim Burger


Also in the News...

8-Year-Old Boy Makes History with Bilateral Hand Transplant Surgery
Unlabeled Meds Lead to $5.1M Verdict
Robotic Surgery Linked to
144 Patient Deaths Over 13-Year Timespan

ASC Employee Who Sent Confidential E-mails to Her Home Convicted of Computer Fraud
Patient Sues Hospital After Surgical Lights Allegedly Cause Severe Burns
15 Surgeons, 17 Hospitals Accused of Using Fake Spinal Hardware
Nation's Largest Anesthesia Billing Company Under Healthcare Fraud Investigation

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?

advertiser banner

Other Articles That May Interest You

News & Notes

Report: Olympus May Have Known About Duodenoscope Problem, Failed to Tell U.S. Providers

Scope maker warned European hospitals about potential risks 2 years ago.

Why Is Medicare Reducing Reimbursements by 1% at More Than 700 Hospitals?